Skip to main content
. Author manuscript; available in PMC: 2020 Nov 10.
Published in final edited form as: Dev Cell. 2018 Aug 9;46(4):441–455.e8. doi: 10.1016/j.devcel.2018.07.012

Figure 7. Abnormal PRKN, SLC25A37, and AIM2 mRNA expression is associated with poor prognosis in human pancreatic cancer.

Figure 7.

(A-F) Prognostic value of PINK1, PRKN, SLC25A37, SCL25A28, HIF1A, and AIM2 in human pancreatic cancer cohorts from the online R2 genomics analysis and visualization platform (https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?&species=hs). (G) Immunohistochemistry stains of PINK1, PRKN, SLC25A37, and AIM2 in pancreatic cancer patients from The Human Protein Atlas platform (http://www.proteinatlas.org/). (H) Schematic depicting the role of mitochondrial quality control and mitochondrial iron in pancreatic tumorigenesis.